Free Trial
→ The Robotics Revolution has arrived … and one $7 stock could take off as a result. (From Weiss Ratings) (Ad)

Analysts Say These 2 Mid-Cap Biotechs Have 2x Potential

Written by MarketBeat Staff
May 18, 2023

unlock icon  Upgrade Now

This premium article is available to MarketBeat All Access subscribers only. Log in to your account or sign up below.

Upgrade Now See Benefits

Already have an account? Log in here.

Should You Invest $1,000 in Denali Therapeutics Right Now?

Before you consider Denali Therapeutics, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Denali Therapeutics wasn't on the list.

While Denali Therapeutics currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

12 Stocks Corporate Insiders are Abandoning Cover
12 Stocks Corporate Insiders are Abandoning

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.

Get This Free Report
Like this article? Share it with a colleague.

Companies Mentioned in This Article

CompanyMarketRank™Current PricePrice ChangeDividend YieldP/E RatioConsensus RatingConsensus Price Target
Denali Therapeutics (DNLI)
4.3146 of 5 stars		$14.96+2.1%N/A-5.36Buy$33.71
Ultragenyx Pharmaceutical (RARE)
3.8092 of 5 stars		$37.35+0.5%N/A-5.89Moderate Buy$88.77
Sarepta Therapeutics (SRPT)
4.8397 of 5 stars		$40.60+2.2%N/A32.20Moderate Buy$122.61
Pfizer (PFE)
4.9916 of 5 stars		$24.07+0.4%7.15%17.04Moderate Buy$29.17
Exelixis (EXEL)
4.5412 of 5 stars		$43.27+0.8%N/A24.55Hold$39.35
Moderna (MRNA)
4.4129 of 5 stars		$27.87-1.0%N/A-2.98Hold$53.58
United Therapeutics (UTHR)
4.8502 of 5 stars		$278.05-15.3%N/A12.71Moderate Buy$393.00
Biogen (BIIB)
4.787 of 5 stars		$134.77+0.5%N/A11.97Hold$191.30
Sanofi (SNY)
3.3265 of 5 stars		$49.94+0.4%3.20%20.07Buy$61.50
Eli Lilly and Company (LLY)
4.9856 of 5 stars		$789.02+2.0%0.76%67.17Moderate Buy$1,011.37
Compare These Stocks  Add These Stocks to My Watchlist 

Featured Articles and Offers

ACT FAST! Congress Is POURING Into This Stock
May 23, 2025

ACT FAST! Congress Is POURING Into This Stock

Lawmakers are making big trades again; Chris Markoch shares 3 big congressional buys, including one surprising pick that’s down over 30%.

Watch Video

Recent Videos

Analysts Are Watching These 4 Penny Stocks—You Should Too
Congress Is Pouring Millions Into These 6 Surprising Stocks
3 Dirt-Cheap Stocks in a Market That’s Getting Expensive

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines